IDC-G305
IDC-G305-2013-001
Phase 1 mab completed
Quick answer
IDC-G305 for Melanoma is a Phase 1 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed